SCHEMBL29528535

SCHEMBL29528535

CN1c2ccccc2N(c2ccc(-c3ccc(-c4nc5ccccc5s4)cc3)cc2)c2ccccc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.60
NPC1 O15118 5/20 0.60
PKM P14618 3/20 0.60
SMN1; SMN2 Q16637 3/20 0.60
KMT2A Q03164 2/20 0.60
NPSR1 Q6W5P4 1/20 0.60
APP P05067 6/20 0.52
KDM4E B2RXH2 4/20 0.52
MAPT P10636 3/20 0.52
GLA P06280 2/20 0.52
GAA P10253 2/20 0.52
MMP9 P14780 2/20 0.52
MMP8 P22894 2/20 0.52
ALDH1A1 P00352 1/20 0.52
LMNA P02545 1/20 0.52
MEN1 O00255 1/20 0.52
PAX8 Q06710 1/20 0.52
NOD2 Q9HC29 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
TNF P01375 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30665633 0.92 RAB9A (0.69) RAB9ANPC1PKMSMN1; SMN2KMT2A
SCHEMBL17879373 0.92 RAB9A (0.69) RAB9ANPC1PKMSMN1; SMN2KMT2A
SCHEMBL17038497 0.89 RAB9A (0.66) RAB9ANPC1PKMSMN1; SMN2KMT2A
SCHEMBL29528524 0.88 RAB9A (0.50) RAB9ANPC1PKMSMN1; SMN2KMT2A
SCHEMBL17404422 0.86 RAB9A (0.47) RAB9ANPC1PKMSMN1; SMN2KMT2A
SCHEMBL29528699 0.84 RAB9A (0.50) RAB9ANPC1PKMSMN1; SMN2KMT2A
SCHEMBL29528914 0.83 RAB9A (0.46) RAB9ANPC1PKMSMN1; SMN2KMT2A
SCHEMBL29529018 0.83 RAB9A (0.49) RAB9ANPC1PKMSMN1; SMN2KMT2A
SCHEMBL17038509 0.82 RAB9A (0.61) RAB9ANPC1PKMSMN1; SMN2KMT2A
SCHEMBL29528518 0.82 RAB9A (0.48) RAB9ANPC1PKMSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11283027-B1 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2022-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11283027-B1 Composition of matter for use in organic light-emitting diodes ALDH1A2, CYBA, CRY2 RAB9A 3307/4885NPC1 863/4885PKM 893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.